SCHEMBL8093151

SCHEMBL8093151

CNC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)c4ccc(OC(F)F)cc4)CC3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
LMNA P02545 3/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
PLK4 O00444 1/20 0.35
AURKA O14965 1/20 0.35
MAPK13 O15264 1/20 0.35
PDPK1 O15530 1/20 0.35
JAK2 O60674 1/20 0.35
ROCK2 O75116 1/20 0.35
MAP4K4 O95819 1/20 0.35
PAK4 O96013 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083973 0.88 ALDH1A1 (0.43) KMT2AMEN1PIK3CAMTORPIK3CG
SCHEMBL8092637 0.88 KMT2A (0.42) KMT2APIK3CAMTORPIK3CGPKM
SCHEMBL8097257 0.87 ALDH1A1 (0.41) KMT2AMEN1LMNAPIK3CAMTOR
SCHEMBL8090246 0.86 PIK3CA (0.42) KMT2AMAPTMEN1HTTNPSR1
SCHEMBL8099749 0.85 MTOR (0.40) KMT2APIK3CAMTORPIK3CG
SCHEMBL8097712 0.84 KMT2A (0.39) KMT2AMEN1PIK3CAMTORPIK3CG
SCHEMBL8089917 0.84 PIK3CA (0.39) KMT2APIK3CAMTORPIK3CGALDH1A1
SCHEMBL8096342 0.82 PIK3CA (0.41) KMT2AMAPTMEN1HTTNPSR1
SCHEMBL8094423 0.82 CA2 (0.43) KMT2AMAPTMEN1LMNAHTT
SCHEMBL3923616 0.81 PIK3CA (0.54) PIK3CAMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed